STAT3: Key targets of growth-promoting receptor positive breast cancer

Bibliographic Details
Title: STAT3: Key targets of growth-promoting receptor positive breast cancer
Authors: Rui-yuan Jiang, Jia-yu Zhu, Huan-ping Zhang, Yuan Yu, Zhi-xin Dong, Huan-huan Zhou, Xiaojia Wang
Source: Cancer Cell International, Vol 24, Iss 1, Pp 1-41 (2024)
Publisher Information: BMC, 2024.
Publication Year: 2024
Collection: LCC:Neoplasms. Tumors. Oncology. Including cancer and carcinogens
LCC:Cytology
Subject Terms: STAT3, Breast cancer, Oncogene, Growth-promoting, Cell growth, Small molecule inhibitors, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282, Cytology, QH573-671
More Details: Abstract Breast cancer has become the malignant tumor with the first incidence and the second mortality among female cancers. Most female breast cancers belong to luminal-type breast cancer and HER2-positive breast cancer. These breast cancer cells all have different driving genes, which constantly promote the proliferation and metastasis of breast cancer cells. Signal transducer and activator of transcription 3 (STAT3) is an important breast cancer-related gene, which can promote the progress of breast cancer. It has been proved in clinical and basic research that over-expressed and constitutively activated STAT3 is involved in the progress, proliferation, metastasis and chemotherapy resistance of breast cancer. STAT3 is an important key target in luminal-type breast cancer and HER2-positive cancer, which has an important impact on the curative effect of related treatments. In breast cancer, the activation of STAT3 will change the spatial position of STAT3 protein and cause different phenotypic changes of breast cancer cells. In the current basic research and clinical research, small molecule inhibitors activated by targeting STAT3 can effectively treat breast cancer, and enhance the efficacy level of related treatment methods for luminal-type and HER2-positive breast cancers.
Document Type: article
File Description: electronic resource
Language: English
ISSN: 1475-2867
Relation: https://doaj.org/toc/1475-2867
DOI: 10.1186/s12935-024-03541-9
Access URL: https://doaj.org/article/3ecbc65b73c8416ca236497f5343ff99
Accession Number: edsdoj.3ecbc65b73c8416ca236497f5343ff99
Database: Directory of Open Access Journals
Full text is not displayed to guests.
More Details
ISSN:14752867
DOI:10.1186/s12935-024-03541-9
Published in:Cancer Cell International
Language:English